Just Earth News | @justearthnews | 24 Nov 2020, 03:32 am Print
Sputnik V Moscow/Sputnik: Over 117,000 doses of Russia's coronavirus vaccine Sputnik V have been already released into the market, and there are plans to produce over 2 million doses by the end of the year, Deputy Prime Minister Tatyana Golikova said on Tuesday.
In August, Sputnik V, developed by the Gamaleya research institute, became the world's first registered vaccine against COVID-19. It is now in phase III post-registration clinical trials.
"Since the moment of Sputnik V state registration, over 117,000 doses of the vaccine have been released into civil circulation. Producers plan to produce over 2 million doses by the year end. Currently, immunization of high-risk groups, doctors and teachers is prioritized," Golikova told the coordination council of human rights commissioners.
- From thinning to thriving? New hair loss treatment is showing promising results in trials
- Surprising coffee link: Daily cups may slow ageing in severe mental illness
- Malaria crisis looms as WHO reveals explosive rise in drug resistance
- Study shows nanoplastics from bottles are not just pollution—They may be harming you from within
- Are birth control pills affecting your mental health? New study raises red flags
-1763561110.jpg "Image of the day: November 19, 2025")
